Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today ...
PLC ("TC BioPharm" or the "Company") , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has ...
Analysts at StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the stock.